It's not just the money: The role of treatment ideology in publicly funded substance use disorder treatment.
MOUD
Nonadopter
Opioid use disorder
Publicly funded treatment
Treatment facility
Journal
Journal of substance abuse treatment
ISSN: 1873-6483
Titre abrégé: J Subst Abuse Treat
Pays: United States
ID NLM: 8500909
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
20
02
2020
revised:
04
08
2020
accepted:
15
10
2020
entrez:
10
12
2020
pubmed:
11
12
2020
medline:
29
7
2021
Statut:
ppublish
Résumé
Medications for opioid use disorder (MOUD) are a first-line treatment for opioid use disorder, yet national surveys indicate that most substance use treatment facilities do not offer MOUD. This article presents the results of a qualitative analysis of interviews with leaders from 25 treatment organizations in Philadelphia, Pennsylvania, that investigated attitudes and barriers toward MOUD. Most treatment organizations that we interviewed are adopting at least one MOUD, suggesting that Philadelphia exceeds the national average of organizations with MOUD capacity. Leaders indicated that both practical resources and ideological barriers thwart adoption and implementation of MOUD in publicly funded substance use disorder treatment agencies. Organizations that had recently adopted MOUDs revealed facilitators to MOUD adoption, such as strong leadership that champions the implementation to staff and redefining recovery from substance use disorders throughout the organization. This study's findings highlight that clients, clinicians, and leadership need to address both practical and ideological barriers to expanding MOUD use.
Identifiants
pubmed: 33298303
pii: S0740-5472(20)30433-5
doi: 10.1016/j.jsat.2020.108176
pmc: PMC7808060
mid: NIHMS1639354
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
108176Subventions
Organisme : NIDA NIH HHS
ID : K23 DA048167
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Références
Psychiatr Serv. 2017 Feb 1;68(2):109-111
pubmed: 27903140
Adm Policy Ment Health. 2011 Jan;38(1):4-23
pubmed: 21197565
Am J Drug Alcohol Abuse. 2018;44(2):151-159
pubmed: 28387530
Health Aff (Millwood). 2019 Jan;38(1):14-23
pubmed: 30615514
Drug Alcohol Depend. 2018 Jun 1;187:171-178
pubmed: 29674251
J Clin Psychol. 2010 Jan;66(1):73-95
pubmed: 19899142
Arch Gen Psychiatry. 2006 Feb;63(2):210-8
pubmed: 16461865
J Addict Med. 2017 Jan/Feb;11(1):1-2
pubmed: 27898497
J Subst Abuse Treat. 2020 Jan;108:115-122
pubmed: 31668516
N Engl J Med. 2017 Dec 14;377(24):2306-2309
pubmed: 29236636
JAMA. 2014 Apr 9;311(14):1393-4
pubmed: 24577059
J Behav Health Serv Res. 2010 Jul;37(3):322-37
pubmed: 19296223
J Stud Alcohol Drugs. 2013 Mar;74(2):258-65
pubmed: 23384373
MMWR Morb Mortal Wkly Rep. 2019 Aug 30;68(34):737-744
pubmed: 31465320
Implement Sci. 2017 Nov 15;12(1):135
pubmed: 29141653
Health Aff (Millwood). 2019 Apr;38(4):643-651
pubmed: 30933576
Med Decis Making. 2001 Jan-Feb;21(1):60-8
pubmed: 11206948
N Engl J Med. 2018 Feb 1;378(5):407-411
pubmed: 29298128
Addict Sci Clin Pract. 2012 Sep 11;7:18
pubmed: 23186374
Am J Addict. 2007 Sep-Oct;16(5):365-71
pubmed: 17882607
Soc Sci Med. 2019 Jul;232:324-331
pubmed: 31125801
Eval Program Plann. 2011 Nov;34(4):375-81
pubmed: 21371752
J Subst Abuse Treat. 2020 Jan;108:82-87
pubmed: 31280928
Drug Alcohol Depend. 2020 Jan 1;206:107735
pubmed: 31790980
J Subst Abuse Treat. 2017 Nov;82:113-121
pubmed: 29021109
Implement Sci. 2018 Sep 19;13(1):121
pubmed: 30231934
Subst Abus. 2016;37(1):47-53
pubmed: 26168816
BMJ. 2017 Apr 26;357:j1550
pubmed: 28446428
Psychiatr Serv. 2019 Oct 1;70(10):958-960
pubmed: 31242831
Cochrane Database Syst Rev. 2014 Feb 06;(2):CD002207
pubmed: 24500948
J Subst Abuse Treat. 2018 Mar;86:30-35
pubmed: 29415848
Psychiatr Serv. 2018 Jun 1;69(6):685-688
pubmed: 29493412
Health Serv Res. 2007 Aug;42(4):1758-72
pubmed: 17286625
JAMA Psychiatry. 2019 Mar 1;76(3):229-230
pubmed: 30586140
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571